Aptevo Therapeutics Inc.

NASDAQ: APVO · Real-Time Price · USD
1.98
-0.06 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
2.02
2.28%
After-hours: Aug 15, 2025, 06:04 PM EDT

Aptevo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-24.13M -17.41M 8.03M -28.46M
Depreciation & Amortization
352K 567K 901K 1.14M
Stock-Based Compensation
1.07M 2.19M 1.8M 1.64M
Other Working Capital
-59K -107K 2.54M -740K
Other Non-Cash Items
n/a 10K -33.9M 6.64M
Deferred Income Tax
n/a n/a n/a 4K
Change in Working Capital
-1.08M 2.91M 2.14M -2.65M
Operating Cash Flow
-23.79M -11.73M -21.02M -21.68M
Capital Expenditures
n/a n/a -29K -713K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -29K -713K
Debt Repayment
n/a -3.47M -12.27M -10.55M
Common Stock Repurchased
n/a -10K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.56M 3.04M 2.72M 26.48M
Financial Cash Flow
15.6M 6M -2.62M 26.16M
Net Cash Flow
-8.19M -5.73M -23.67M 3.77M
Free Cash Flow
-23.79M -11.73M -21.05M -22.39M